The Function of the Vitamin D Receptor and a Possible Role of Enhancer RNA in Epigenomic Regulation of Target Genes: Implications for Bone Metabolism

키워드

참고문헌 (53)

1. Morris HA, "Autocrine and paracrine actions of vitamin D", Clin Biochem Rev, 31, pp.129~138 (2010)
2. Feldman D, "Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets", Bonekey Rep, 3, pp.510~ (2014)
3. Kato S, "The function of vitamin D receptor in vitamin D action", J Biochem, 127, pp.717~722 (2000)
4. Haussler MR, "The nuclear vitamin D receptor: biological and molecular regulatory properties revealed", J Bone Miner Res, 13, pp.325~349 (1998)
5. Matsumoto T, "A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures-a randomized, active comparator, double-blind study", Bone, 49, pp.605~612 (2011)
6. Andersson R, "An atlas of active enhancers across human cell types and tissues", Nature, 507, pp.455~461 (2014)
7. Djebali S, "Landscape of transcription in human cells", Nature, 489, pp.101~108 (2012)
8. Takeyama K, "25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis", Science, 277, pp.1827~1830 (1997)
9. Kitanaka S, "Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets", N Engl J Med, 338, pp.653~661 (1998)
10. Yoshizawa T, "Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning", Nat Genet, 16, pp.391~396 (1997)
11. Mangelsdorf DJ, "The nuclear receptor superfamily: the second decade", Cell, 83, pp.835~839 (1995)
12. Pike JW, "Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand", Mol Cell Endocrinol, 347, pp.3~10 (2011)
13. Lupien M, "FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription", Cell, 132, pp.958~970 (2008)
14. Zaret KS, "Pioneer transcription factors, chromatin dynamics, and cell fate control", Curr Opin Genet Dev, 37, pp.76~81 (2016)
15. Seuter S, "Epigenomic PU.1-VDR crosstalk modulates vitamin D signaling", Biochim Biophys Acta Gene Regul Mech, 1860, pp.405~415 (2017)
16. Rachez C, "A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system", Genes Dev, 12, pp.1787~1800 (1998)
17. Rosenfeld MG, "Sensors and signals: a coactivator", corepressor, Genes Dev, pp.2006, 20[DOI]
18. Kato S, "receptor coregulators merge transcriptional coregulation with epigenetic regulation", Trends Biochem Sci, 36, pp.272~281 (2011)
19. Seuter S, "Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1alpha,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression", Nucleic Acids Res, 41, pp.110~124 (2013)
20. Battaglia S, "LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer", Clin Epigenetics, 9, pp.82~ (2017)
21. Masuyama R, "Dietary phosphorus restriction reverses the impaired bone mineralization in vitamin D receptor knockout mice", Endocrinology, 142, pp.494~497 (2001)
22. Yamamoto Y, "Vitamin D receptor in osteoblasts is a negative regulator of bone mass control", Endocrinology, 154, pp.1008~1020 (2013)
23. Uenishi K, "Stimulation of intestinal calcium absorption by orally administrated vitamin D3 compounds: a prospective open-label randomized trial in osteoporosis", Osteoporos Int, 29, pp.723~732 (2018)
24. Bouillon R, "Vitamin D and human health: lessons from vitamin D receptor null mice", Endocr Rev, 29, pp.726~776 (2008)
25. Lieben L, "Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization", J Clin Invest, 122, pp.1803~1815 (2012)
26. Nakamura T, "Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol", J Bone Miner Metab, 31, pp.417~422 (2013)
27. Sakai Y, "Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice", J Clin Invest, 107, pp.961~966 (2001)
28. Esteller M, "Non-coding RNAs in human disease", Nat Rev Genet, 12, pp.861~874 (2011)
29. Meyer MB, "Genomic determinants of gene regulation by 1,25-dihydroxyvitamin D3 during osteoblast-lineage cell differentiation", J Biol Chem, 289, pp.19539~19554 (2014)
30. Seuter S, "Dynamics of 1alpha, 25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes", Biochim Biophys Acta, 1829, pp.1266~1275 (2013)
31. Luger K, "New insights into nucleosome and chromatin structure: an ordered state or a disordered affair?", Nat Rev Mol Cell Biol, 13, pp.436~447 (2012)
32. Allis CD, "New nomenclature for chromatin-modifying enzymes", Cell, 131, pp.633~636 (2007)
33. Suganuma T, "Signals and combinatorial functions of histone modifications", Annu Rev Biochem, 80, pp.473~499 (2011)
34. Tan M, "Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification", Cell, 146, pp.1016~1028 (2011)
35. Fujiki R, "GlcNAcylation of histone H2B facilitates its monoubiquitination", Nature, 480, pp.557~560 (2011)
36. Baba A, "PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B", Nat Cell Biol, 13, pp.668~675 (2011)
37. Greer EL, "Histone methylation: a dynamic mark in health, disease and inheritance", Nat Rev Genet, 13, pp.343~357 (2012)
38. Chen T, "Chromatin modifiers and remodellers: regulators of cellular differentiation", Nat Rev Genet, 15, pp.93~106 (2014)
39. Kato S, "Point mutations in an epigenetic factor lead to multiple types of bone tumors: role of H3.3 histone variant in bone development and disease", Bonekey Rep, 4, pp.715~ (2015)
40. Burgess RJ, "Histone chaperones in nucleosome assembly and human disease", Nat Struct Mol Biol, 20, pp.14~22 (2013)
41. Sawatsubashi S, "A histone chaperone, DEK, transcriptionally coactivates a nuclear receptor", Genes Dev, 24, pp.159~170 (2010)
42. Metzger E, "LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription", Nature, 437, pp.436~439 (2005)
43. Ren B, "A CRISPR connection between chromatin topology and genetic disorders", Cell, 161, pp.955~957 (2015)
44. Hnisz D, "A phase separation model for transcriptional control", Cell, 169, pp.13~23 (2017)
45. Kim TK, "Architectural and functional commonalities between enhancers and promoters", Cell, 162, pp.948~959 (2015)
46. Neme A, "Vitamin D-dependent chromatin association of CTCF in human monocytes", Biochim Biophys Acta, 1859, pp.1380~1388 (2016)
47. Li W, "Enhancers as non-coding RNA transcription units: recent insights and future perspectives", Nat Rev Genet, 17, pp.207~223 (2016)
48. Li W, "Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation", Nature, 498, pp.516~520 (2013)
49. Lam MT, "Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription", Nature, 498, pp.511~515 (2013)
50. Sawatsubashi S, "Development of versatile non-homologous end joining-based knock-in module for genome editing", Sci Rep, 8, pp.593~ (2018)
51. Meyer MB, "A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3", J Biol Chem, 285, pp.15599~15610 (2010)
52. Tsai PF, "A muscle-specific enhancer RNA mediates cohesin recruitment and regulates transcription in trans", Mol Cell, 71, pp.129~141.e8 (2018)
53. Weintraub AS, "YY1 Is a structural regulator of enhancer-promoter loops", Cell, 171, pp.1573~1588.e28 (2017)

관련 논문AI추천